Crispr Therapeutics Ag (CRSP)
39.51 -1.38 (-3.39%) 14:32 ET [NASDAQ]
39.48 x 12 39.54 x 200
Realtime by (Cboe BZX)
39.48 x 12 39.54 x 200
Realtime 40.92 +0.03 (+0.07%) 09:25 ET
for Wed, Mar 26th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CRSP | ALVO | RYTM | ||
| Company | Crispr Therapeutics Ag | Alvotech | Rhythm Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 40.80 | 11.68 | 52.89 | ||
| High | 40.88 | 11.70 | 54.90 | ||
| Low | 39.15 | 11.41 | 52.54 | ||
| Last | 39.51 | 11.43 | 53.47 | ||
| Change | -1.38 | -0.23 | +0.56 | ||
| % Change | -3.37% | -1.97% | +1.06% | ||
| Volume | 1,498,862 | 46,753 | 204,629 | ||
| 20-Day Average Volume | 1,583,308 | 102,845 | 542,597 | ||
| Previous Close | 40.89 | 11.66 | 52.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 42.50 | 11.27 | 52.30 | ||
| 20-Day Raw Stochastic | 0.00% | 69.23% | 67.10% | ||
| 20-Day Relative Strength | 41.95% | 45.70% | 48.28% | ||
| Weighted Alpha | -44.41 | -9.17 | +4.30 | ||
| Today's Opinion | 100% Sell | 64% Sell | 8% Sell | ||
| Previous Opinion | 96% Sell | 56% Sell | 8% Sell | ||
| Last Month's Opinion | 40% Sell | 24% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.65% since 03/19/25 | +0.97% since 03/19/25 | -3.58% since 03/19/25 | ||
| Low | 39.15 on 03/26/25 | 11.37 on 03/20/25 | 51.87 on 03/21/25 | ||
| High | 42.72 on 03/24/25 | 11.77 on 03/20/25 | 55.31 on 03/20/25 | ||
| 1-Month | |||||
| %Chg | -11.82% since 02/26/25 | -2.72% since 02/26/25 | -0.16% since 02/26/25 | ||
| Low | 39.15 on 03/26/25 | 10.46 on 03/11/25 | 47.86 on 03/10/25 | ||
| High | 46.78 on 02/27/25 | 11.89 on 02/27/25 | 55.87 on 03/19/25 | ||
| 3-Month | |||||
| %Chg | -4.67% since 12/26/24 | -9.13% since 12/26/24 | -5.85% since 12/26/24 | ||
| Low | 36.52 on 01/13/25 | 10.46 on 03/11/25 | 47.86 on 03/10/25 | ||
| High | 55.88 on 02/19/25 | 13.70 on 01/13/25 | 62.14 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -15.79% since 09/26/24 | +0.88% since 09/26/24 | +4.12% since 09/26/24 | ||
| Low | 36.52 on 01/13/25 | 9.15 on 10/17/24 | 46.80 on 10/10/24 | ||
| High | 59.07 on 11/11/24 | 13.70 on 01/13/25 | 68.58 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,507,299 | 3,515,280 | 3,345,181 | ||
| Shares Outstanding, K | 85,774 | 301,482 | 63,224 | ||
| Annual Sales | 37,310,000 | 91,430,000 | 130,130,000 | ||
| Annual Net Income | -366,250,000 | -551,730,000 | -260,600,000 | ||
| Last Quarter Sales | 35,690,000 | 102,990,000 | 41,830,000 | ||
| Last Quarter Net Income | -37,310,000 | -11,390,000 | -43,330,000 | ||
| 60-Month Beta | 1.77 | -0.16 | 2.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 02/11/25 | 0.19 on 11/13/24 | -0.72 on 02/26/25 | ||
| Latest Earnings Date | 05/14/25 | 03/26/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||